Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2009-02-08 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 55 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document contains a Form 10-Q filing for the quarterly period ended December 31, 2008, as indicated by the SEC header and the explicit mention of 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934'. It includes detailed unaudited condensed consolidated financial statements, management's discussion and analysis, and other required disclosures typical of an interim quarterly report. The presence of financial statements and substantive financial data confirms it is a financial report rather than an announcement or certification. Therefore, the document is classified as an Interim / Quarterly Report (IR). H1 2009
2009-02-08 English
Record Financial Results For The Qtr Ended Dec 31, 2008 4 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of financial results for the quarter and six months ended December 31, 2008, including revenue, income, expenses, earnings per share, and balance sheet data. It contains comprehensive financial statements such as Consolidated Statements of Income and Balance Sheets, with actual financial figures and analysis. The presence of detailed quarterly financial data and management commentary indicates this is a quarterly financial report. The document also mentions a conference call to discuss these quarterly results, which is typical for interim/quarterly reports. It is not merely an earnings release (which would be shorter and less detailed), nor is it an annual report or audit report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2009
2009-02-05 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's personal share transactions, including the number of shares held before and after the transaction, the nature of the transaction (trade pursuant to US SEC regulation 10b5-1 trading plan), and the value of shares disposed. There is no financial performance data, earnings information, or report publication mentioned. The content strictly relates to insider trading activities by a company director. Therefore, this document fits the category of Director's Dealing (DIRS).
2009-02-03 English
Top 20 securityholders 1 page ?Kb
Major Shareholding Notification Classification · 100% confidence The document lists the top 20 holders of common stock units (CDIs) for ResMed Inc as of January 30, 2009. It is a detailed listing of major shareholders and their holdings, showing percentages of issued capital. There is no indication of a report, financial results, management discussion, or any other type of filing. This is a notification of significant share ownership levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding data, confirming it is not a full report or announcement of a report publication.
2009-02-03 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about securities issued or to be issued, including class, number, terms, and quotation details. The document references ASX rules and is clearly an announcement related to capital changes, specifically new securities issuance and quotation application. There is no indication of financial statements, management discussion, or audit information. The content aligns with announcements about share issues or capital structure changes rather than a full report or regulatory filing. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is substantial (15,000 characters), indicating it is not a mere announcement of a report but the actual detailed announcement of a capital change.
2009-02-03 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's personal share transactions, including the number of shares held before and after the transaction, the nature of the transaction (trade pursuant to US SEC regulation 10b5-1 trading plan), and the value of shares disposed. This matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 2902 characters, which is consistent with a detailed notice rather than a brief announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2009-01-28 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.